KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Medpace Holdings (MEDP) Gross Profit (2016 - 2025)

Historic Gross Profit for Medpace Holdings (MEDP) over the last 11 years, with Q3 2025 value amounting to $196.9 million.

  • Medpace Holdings' Gross Profit rose 1652.64% to $196.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $733.6 million, marking a year-over-year increase of 1932.76%. This contributed to the annual value of $656.3 million for FY2024, which is 2512.85% up from last year.
  • Medpace Holdings' Gross Profit amounted to $196.9 million in Q3 2025, which was up 1652.64% from $180.0 million recorded in Q2 2025.
  • Over the past 5 years, Medpace Holdings' Gross Profit peaked at $196.9 million during Q3 2025, and registered a low of $74.7 million during Q2 2021.
  • Moreover, its 5-year median value for Gross Profit was $130.2 million (2023), whereas its average is $131.4 million.
  • Per our database at Business Quant, Medpace Holdings' Gross Profit surged by 619.42% in 2021 and then soared by 3667.46% in 2022.
  • Over the past 5 years, Medpace Holdings' Gross Profit (Quarter) stood at $88.0 million in 2021, then skyrocketed by 31.54% to $115.7 million in 2022, then grew by 18.21% to $136.8 million in 2023, then soared by 30.34% to $178.3 million in 2024, then grew by 10.44% to $196.9 million in 2025.
  • Its last three reported values are $196.9 million in Q3 2025, $180.0 million for Q2 2025, and $178.4 million during Q1 2025.